Hims & Hers Health (NYSE: HIMS), the telehealth company famous for selling Ozempic lookalikes over the internet, is tumbling ...

Hims’ second-quarter revenue fell 7% from a quarter ago. The decline goes beyond weakness in its GLP-1 weight-loss business.

Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and ...

Now, it’s worth noting Stock Advisor’s total average return is 1,039% — a market-crushing outperformance compared to 181 % for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

U.S. equities declined in Tuesday’s midday trade after surging during the morning session, after President Donald Trump ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Investing.com - Truist Securities在Hims and Hers(NYSE:HIMS)公布2025财年第二季度财务业绩后，维持其"持有"评级和48.00美元的目标价。这家市值129亿美元的远程医疗公司，根据InvestingPro分析，尽管过去一年回报率超过255%，但目前股价水平似乎被高估。 该远程医疗公司报告的收入略低于市场预期，同时维持其2025年指引，现包括其 ...

NEW YORK (AP) — Wall Street is holding steadier on Tuesday following its see-saw ride that bracketed the weekend.

Futures linked to Canada's main stock index rose on Tuesday, boosted by higher chance of the U.S. Federal Reserve cutting ...

Former X CEO Linda Yaccarino has taken the helm at eMed Population Health, marking a bold shift from social media to digital healthcare leadership amid rising demand for weight-loss drugs and ...